| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Gene Therapy Research Unit, Centenary Institute of Cancer Medicine and Cell Biology, Newtown New South Wales 2042, Australia [J. E. J. R.]; Department of Biochemistry, University of Oxford, Oxford OX1 3QU United Kingdom [E. M. K., A. F. R.]; Biologia Molecular, Universidad de Cantabria Facultad de Medicina, 39011 Santander, Spain [J. L.]; Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [G. N. F., Y. J. H., J. U., M. D. W., P. E. N., S. J. C.]; and Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892 [D. I. L., S. V., E. M. P., H. C. M., V. V. L.]
The 11-zinc finger protein CCTC-binding factor (CTCF) employs different sets of zinc fingers to form distinct complexes with varying CTCF- target sequences (CTSs) that mediate the repression or activation of gene expression and the creation of hormone-responsive gene silencers and of diverse vertebrate enhancer-blocking elements (chromatin insulators). To determine how these varying effects would integrate in vivo, we engineered a variety of expression systems to study effects of CTCF on cell growth. Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis. In asynchronous cultures, the cell-cycle profile of CTCF-expressing cells remained unaltered, which suggested that progression through the cycle was slowed at multiple points. Although conditionally induced CTCF caused the S-phase block, CTCF can also arrest cell division. Viable CTCF-expressing cells could be maintained without dividing for several days. While MYC is the well-characterized CTCF target, the inhibitory effects of CTCF on cell growth could not be ascribed solely to repression of MYC, suggesting that additional CTS-driven genes involved in growth-regulatory circuits, such as p19ARF, are likely to contribute to CTCF-induced growth arrest. These findings indicate that CTCF may regulate cell-cycle progression at multiple steps within the cycle, and add to the growing evidence for the function of CTCF as a tumor suppressor gene.
This article has been cited by other articles:
![]() |
F. Docquier, G.-X. Kita, D. Farrar, P. Jat, M. O'Hare, I. Chernukhin, S. Gretton, A. Mandal, L. Alldridge, and E. Klenova Decreased Poly(ADP-Ribosyl)ation of CTCF, a Transcription Factor, Is Associated with Breast Cancer Phenotype and Cell Proliferation Clin. Cancer Res., September 15, 2009; 15(18): 5762 - 5771. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Guastafierro, B. Cecchinelli, M. Zampieri, A. Reale, G. Riggio, O. Sthandier, G. Zupi, L. Calabrese, and P. Caiafa CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation Machinery J. Biol. Chem., August 8, 2008; 283(32): 21873 - 21880. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Majumder, J. A. Gomez, B. P. Chadwick, and J. M. Boss The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions J. Exp. Med., April 14, 2008; 205(4): 785 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chernukhin, S. Shamsuddin, S. Y. Kang, R. Bergstrom, Y.-W. Kwon, W. Yu, J. Whitehead, R. Mukhopadhyay, F. Docquier, D. Farrar, et al. CTCF Interacts with and Recruits the Largest Subunit of RNA Polymerase II to CTCF Target Sites Genome-Wide Mol. Cell. Biol., March 1, 2007; 27(5): 1631 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghochikyan, M. Mkrtichyan, D. Loukinov, G. Mamikonyan, S. D. Pack, N. Movsesyan, T. E. Ichim, D. H. Cribbs, V. V. Lobanenkov, and M. G. Agadjanyan Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites J. Immunol., January 1, 2007; 178(1): 566 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Chau, X.-Y. Zhang, S. B. McMahon, and P. M. Lieberman Regulation of Epstein-Barr Virus Latency Type by the Chromatin Boundary Factor CTCF. J. Virol., June 1, 2006; 80(12): 5723 - 5732. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Torrano, J. Navascues, F. Docquier, R. Zhang, L. J. Burke, I. Chernukhin, D. Farrar, J. Leon, M. T. Berciano, R. Renkawitz, et al. Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism J. Cell Sci., May 1, 2006; 119(9): 1746 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Torrano, I. Chernukhin, F. Docquier, V. D'Arcy, J. Leon, E. Klenova, and M. D. Delgado CTCF Regulates Growth and Erythroid Differentiation of Human Myeloid Leukemia Cells J. Biol. Chem., July 29, 2005; 280(30): 28152 - 28161. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Docquier, D. Farrar, V. D'Arcy, I. Chernukhin, A. F. Robinson, D. Loukinov, S. Vatolin, S. Pack, A. Mackay, R. A. Harris, et al. Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis Cancer Res., June 15, 2005; 65(12): 5112 - 5122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishizaki, M. Yoshie, Y. Yaginuma, T. Tanaka, and K. Ogawa Loss of Igf2 Imprinting in Monoclonal Mouse Hepatic Tumor Cells Is Not Associated with Abnormal Methylation Patterns for the H19, Igf2, and Kvlqt1 Differentially Methylated Regions J. Biol. Chem., February 14, 2003; 278(8): 6222 - 6228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Qi, A. Martensson, M. Mattioli, R. Dalla-Favera, V. V. Lobanenkov, and H. C. Morse III CTCF functions as a critical regulator of cell-cycle arrest and death after ligation of the B cell receptor on immature B cells PNAS, January 21, 2003; 100(2): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Loukinov, E. Pugacheva, S. Vatolin, S. D. Pack, H. Moon, I. Chernukhin, P. Mannan, E. Larsson, C. Kanduri, A. A. Vostrov, et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma PNAS, May 14, 2002; 99(10): 6806 - 6811. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |